How to NavigateEcosystem ConnectDistinguished InvestigatorsGlobal ConferencesRLT EducationRLT ComponentsSponsorsTrial Stats
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Description:
This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for advanced soft tissue sarcomas.
Sponsor:
Ruijin Hospital
Government Study Link:
NCT06644287 - Click here to see study onClinicalTrials.gov
68Ga-grazytracer
Isotope(s):
Target(s):
- Granzyme B
